Navigation Links
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of MAP Pharmaceuticals, Inc. - MAPP

NEW YORK, Jan. 23, 2013 /PRNewswire/ -- Pomerantz Grossman Hufford Dahlstrom & Gross LLP is investigating claims on behalf of investors of MAP Pharmaceuticals, Inc. ("MAP Pharmaceuticals" or the "Company") (NASDAQ: MAPP) (ISIN: US56509R1086) (CUSIP: 56509R108) concerning the proposed acquisition of MAP Pharmaceuticals by Allergan, Inc. in a transaction valued at approximately $985 million in cash.

The investigation concerns whether the MAP Pharmaceuticals directors are breaching their fiduciary duties by failing to adequately shop the Company and maximize shareholder value.  Under the terms of the agreement, MAP Pharmaceuticals shareholders will be entitled to receive $25.00 per share in cash for each share of MAP Pharmaceuticals common stock.  However, at least one analyst noted that the offered price undervalues MAP Pharmaceuticals' new migraine treatment drug Levadex.

MAP Pharmaceuticals shareholders seeking more information about this acquisition are advised to contact Robert Willoughby at or 212-661-1100 or 888-476-6529, ext. 237.

The firm is also investigating actions on behalf of shareholders for the following companies: Arbitron Inc., Net1 Ueps Technologies, Inc., Hi-Crush Partners LP, Intermec, Inc., SandRidge Energy, Inc., Abiomed, Inc., Universal Technical Institute, and Clearwire Corporation, Ameristar Casinos, Inc. K-Swiss, Inc., Neptune Technologies Bioressources, Inc. Telanetix, Inc.

The Pomerantz Firm, with offices in New York, Chicago and San Diego, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz , known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 75 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of defrauded investors. See

SOURCE Pomerantz Grossman Hufford Dahlstrom & Gross LLP
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. BD Announces Webcast of Annual Meeting of Shareholders
2. Accelr8 to Hold 2012 Annual Meeting of Shareholders; Product Development Continues with Launch Expected in 2015
3. SHAREHOLDER ALERT: Morgan & Morgan announces an investigation of Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) and whether senior management and the board of directors violated fiduciary duties owed to Vertex shareholders.
4. Delaware Court of Chancery Dismisses Vermillion Dissident Shareholder Suit with Prejudice
5. SurgLine International, Inc. Shareholder Update
6. Ampio Provides Progress Report on Clinical Programs in Preparation for Annual Shareholders Meeting
7. Cannabis Science Provides Corporate Guidance on Preclinical Initiatives and Recent Corporate Developments for its Shareholders; CBIS Announces plans for 1st Q of 2013 Webinar Investor Call
8. Winner Medical Announces Mailing of Definitive Proxy Materials for Special Meeting of Shareholders
9. WuXi PharmaTech Announces Shareholder Resolutions Adopted at 2012 Annual General Meeting
10. Medbox Announces Increase in Shareholder Base and Record Revenue Generated in Q3
11. Cardinal Health Announces Preliminary Shareholder Voting Results at 2012 Annual Meeting
Post Your Comments:
(Date:10/12/2015)... Corporation (NASDAQ: LMNX ) today announced that it expects ... 2015 on Monday, November 2, 2015. A press release announcing ... trading. --> --> ... highlights and financial results for the third quarter ended September ... time. . Simply log on to ...
(Date:10/12/2015)...  Millions of smokers worldwide have used vaping to ... An April 2015 study released by a ... cigarettes to be up to 95 percent less harmful ... after the technology was first introduced the potentially harmful ... --> --> Palm Beach Vapors, ...
(Date:10/12/2015)...  In a Sutter Institute of Medical Research study ... and Psychiatry, the blood product intravenous immunoglobulin, or IVIG, ... in patients in the early, pre-dementia phase of Alzheimer,s ... IVIG, extracted from the plasma of more than 1,000 ... protein found in patients with Alzheimer,s disease. Sutter Institute ...
Breaking Medicine Technology:
(Date:10/13/2015)... ... , ... The Bill Howe Family of Companies is an award winning HVAC ... remediation services. Family-owned and operated for 35 years, they have maintained value, ethics and ... two years in a row from the Union Tribune Reader’s Poll, a Healthiest Company ...
(Date:10/13/2015)... ... 13, 2015 , ... Doulagivers is O'Brien's licensed training program ... End of Life Doula Training. A Doulagiver is a non-medical person trained to ... Based on her #1 International bestselling book Creating Positive Passings & The Level ...
(Date:10/12/2015)... (PRWEB) , ... October 13, 2015 , ... North American ... (IBC) at the 2015 IBC National Meeting in Rosemont, IL on October 4th. ... dedication, quality, and standards of excellence that customers have come to expect from members ...
(Date:10/12/2015)... ... October 12, 2015 , ... According to an ... female athletes, particularly in the area of track and field, are at a ... than male peers in the same age group. Dr. Steven Meier of Meier ...
(Date:10/12/2015)... ... 12, 2015 , ... The American Society of Clinical Hypnosis ... education and clinical training in a health care discipline. , Many practitioners ... as: losing weight, managing pain, or stopping smoking, etc. Frequently, extravagant statements and ...
Breaking Medicine News(10 mins):